Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index; 1 of the 9 sources its claims cite were checked for support.
Abstract
BACKGROUND: The severe acute respiratory syndrome (SARS) has recently been identified as a new clinical entity. SARS is thought to be caused by an unknown infectious agent. METHODS: Clinical specimens from patients with SARS were searched for unknown viruses with the use of cell cultures and molecular techniques. RESULTS: A novel coronavirus was identified in patients with SARS. The virus was isolated in cell culture, and a sequence 300 nucleotides in length was obtained by a polymerase-chain-reaction (PCR)-based random-amplification procedure. Genetic characterization indicated that the virus is only distantly related to known coronaviruses (identical in 50 to 60 percent of the nucleotide sequence). On the basis of the obtained sequence, conventional and real-time PCR assays for specific and sensitive detection of the novel virus were established. Virus was detected in a variety of clinical specimens from patients with SARS but not in controls. High concentrations of viral RNA of up to 100 million molecules per milliliter were found in sputum. Viral RNA was also detected at extremely low concentrations in plasma during the acute phase and in feces during the late convalescent phase. Infected patients showed seroconversion on the Vero cells in which the virus was isolated. CONCLUSIONS: The novel coronavirus might have a role in causing SARS.
Overview
CoChat Summary
## TL;DR
The paper identifies a previously unknown coronavirus in patients with severe acute respiratory syndrome (SARS) and provides PCR and serologic evidence linking it to the illness. It also reports that viral RNA was found at very high levels in sputum, with lower-level detection in plasma and later in stool, supporting a respiratory infection with possible additional shedding routes.
## Key findings
- A novel coronavirus was isolated from sputum of the index patient after 6 days of incubation in Vero-cell culture, and a 300-nucleotide sequence was obtained by random RT-PCR.
- Genetic analysis found the virus was only distantly related to known coronaviruses, with the BNI-1 sequence differing by 39% to 46% from known sequences and by 50% to 60% identical nucleotide sequence to known coronaviruses.
- In the Hanoi outbreak panel, the virus was detected in 100% of patients with probable SARS, 23% of those with suspected SARS, and 0% of healthy contacts.
- Quantitative PCR found viral RNA concentrations of up to 100 million molecules per milliliter in sputum; the index patient also had RNA in plasma at 190 (day 9) and stool on day 25, and Contact 1 had 6.3 × 10^4 in sputum and 4.1 × 10^5 in BAL.
## Methods
- Clinical specimens from SARS patients were screened for known and unknown pathogens using cell culture, electron microscopy, PCR, antigen ELISA, serology, and sequence/phylogenetic analysis.
- The study examined specimens from 3 patients in Frankfurt (index patient, Contact 1, Contact 2) and a panel of 49 specimens from 18 suspected/probable SARS patients and 21 healthy contacts in Hanoi, plus 54 stool controls from Germany.
- A random RT-PCR approach and subsequent nested and real-time RT-PCR assays were developed to identify and quantify the novel virus, with specificity tested against several other coronaviruses.
## Limitations
- The paper itself states that larger studies with appropriate control groups are needed to verify or reject the hypothesis that this virus causes SARS.
- The authors note that the antibody response might not be definitively directed against the novel coronavirus, because the antigen used in serology came from primary cultures; they say this should be tested with plaque-purified virus or recombinant proteins.
- Evidence of causation is not established here; the paper shows association and detection in patients, but the conclusion is only that the virus “might have a role” in causing SARS.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 0 Not valid · 7 Not checked · 67 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The presence of viral RNA in stool of the patients late during convalescence is reminiscent of characteristics of other coronaviruses. 13”
What the sources say
- Partly supportedcites [13] matched to “Evaluation of concurrent shedding of bovine coronavirus via the respiratory tract and enteric route in feedlot cattle” (2001) sourceExperimental — accuracy not yet measured
Our copy of Cho et al (2001) supports only the general point that a bovine coronavirus is present/shed in feces: fecal samples from 56 feedlot steers were positive for BCV by antigen-capture ELISA and virus isolation (Results, p. 1; Materials and Methods, Sample Collections), and the Discussion (p. 6) notes 22% of fecal samples from cattle without diarrhea were antigen-positive, suggesting they 'had diarrhea during shipping or at the auction barn and were still shedding BCV'. The specific elements the citing sentence attributes are absent: detection was of antigen/infectious virus, not viral RNA (no RT-PCR assay appears anywhere in our copy; RT-PCR of feces belongs to a work it cites, Tsunemitsu and Saif, ref 35), samples were taken only on days 0, 4, 14 and 21 after arrival rather than late during convalescence, in cattle rather than human patients, and the paper makes no comparative statement about shared characteristics of other coronaviruses. (LLM, conf=0.62)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Infected patients showed seroconversion on the Vero cells in which the virus was isolated.”
- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“About 20 distinct DNA fragments were obtained and sequenced.”
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Three of the fragments did not match any nucleotide sequence in the data base.”
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“since there was serologic evidence of an acute infection with this virus in our index patient and also in Contact 1”
plainn = 2- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
50 more claims
Create a free account to see all 75 claims and to verify the 7 references still open.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 11
Citations
Cites
PHYLIP-Phylogeny inference package (Version 3.2)
Felsenstein, J. (1989) · Cladistics · Cited by 17,682
Identification of Severe Acute Respiratory Syndrome in Canada
Poutanen, S. M., Low, D. E., Henry, B., Finkelstein, S., Rose, D., Green, K., Tellier, R., Draker, R., Adachi, D., Ayers, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030634 · Cited by 1,132
A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong
Tsang, K. W., Ho, P. L., Ooi, G. C., Yee, W. K., Wang, T., Chan-Yeung, M., Lam, W. K., Seto, W. H., Yam, L. Y., Cheung, T. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030666 · Cited by 1,017
Viruses and bacteria in the etiology of the common cold
Mäkelä, M. J., Puhakka, T., Ruuskanen, O., Leinonen, M., Saikku, P., Kimpimäki, M., Blomqvist, S., Hyypiä, T., & Arstila, P. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.2.539-542.1998 · Cited by 768
Drosten, C., Göttig, S., Schilling, S., Asper, M., Panning, M., Schmitz, H., & Günther, S. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.7.2323-2330.2002 · Cited by 631
Self-citationImported Lassa Fever in Germany: Molecular Characterization of a New Lassa Virus Strain
Günther, S., Emmerich, P., Laue, T., Kühle, O., Asper, M., Jung, A., Grewing, T., ter Meulen, J., & Schmitz, H. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0605.000504 · Cited by 200
Self-citationStephensen, C. B., Casebolt, D. B., & Gangopadhyay, N. N. (1999) · Virus Research · doi:10.1016/s0168-1702(99)00017-9 · Cited by 135
Cho, K.-O., Hoet, A. E., Loerch, S. C., Wittum, T. E., & Saif, L. J. (2001) · American Journal of Veterinary Research · doi:10.2460/ajvr.2001.62.1436 · Cited by 88
TTV a common virus, but pathogenic?
Cossart, Y. E. (1998) · The Lancet · doi:10.1016/s0140-6736(05)77802-8 · Cited by 44
HGV: hepatitis G virus or harmless G virus?
Kew, M. C., & Kassianides, C. (1996) · The Lancet · doi:10.1016/s0140-6736(96)98020-4 · Cited by 39
Research works printed but not linked: 2
- 2003, Wkly Epidemiol Rec, 78, 81
- 2003, Wkly Epidemiol Rec, 78, 73
Cited by
Items 901–1,000 of 1,020
Chen, C., Lee, C., Liu, C.-Y., Wang, J.-H., Wang, L.-M., & Perng, R.-P. (2005) · Journal of the Chinese Medical Association · doi:10.1016/s1726-4901(09)70124-8 · Cited by 101
Keng, C. T., Zhang, A., Shen, S., Lip, K.-M., Fielding, B. C., Tan, T. H. P., Chou, C.-F., Loh, C. B., Wang, S., Fu, J., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3289-3296.2005 · Cited by 102
Drosten, C., Chiu, L.-L., Panning, M., Leong, H. N., Preiser, W., Tam, J. S. L., Günther, S., Kramme, S., Emmerich, P., Ng, W. L., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.5.2043-2047.2004 · Cited by 107
Self-citationPriming Time: How Cellular Proteases Arm Coronavirus Spike Proteins
Hoffmann, M., Hofmann-Winkler, H., & Pöhlmann, S. (2018) · Activation of Viruses by Host Proteases · doi:10.1007/978-3-319-75474-1_4 · Cited by 95
COVID-19 transmission and blood transfusion: A case report
Cho, H. J., Koo, J. W., Roh, S. K., Kim, Y. K., Suh, J. S., Moon, J. H., Sohn, S. K., & Baek, D. W. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.05.001 · Cited by 101
Yang, L., Liu, W., Yu, X., Wu, M., Reichert, J. M., & Ho, M. (2020) · Antibody Therapeutics · doi:10.1093/abt/tbaa020 · Cited by 103
Bat-infecting merbecovirus HKU5-CoV lineage 2 can use human ACE2 as a cell entry receptor
Chen, J., Zhang, W., Li, Y., Liu, C., Dong, T., Chen, H., Wu, C., Su, J., Li, B., Zhang, W., et al. (2025) · Cell · doi:10.1016/j.cell.2025.01.042 · Cited by 108
Zhou, M., Xu, D., Li, X., Li, H., Shan, M., Tang, J., Wang, M., Wang, F., Zhu, X., Tao, H., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2138 · Cited by 104
He, Y., Zhu, Q., Liu, S., Zhou, Y., Yang, B., Li, J., & Jiang, S. (2005) · Virology · doi:10.1016/j.virol.2005.01.034 · Cited by 101
Shie, J., Fang, J., Kuo, T., Kuo, C., Liang, P., Huang, H., Wu, Y.-T., Jan, J., Cheng, Y. E., & Wong, C. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.05.065 · Cited by 111
Structure-Based Design, Synthesis, and Evaluation of Peptide-Mimetic SARS 3CL Protease Inhibitors
Akaji, K., Konno, H., Mitsui, H., Teruya, K., Shimamoto, Y., Hattori, Y., Ozaki, T., Kusunoki, M., & Sanjoh, A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200870n · Cited by 100
Aiello, F., Afflitto, G. G., Mancino, R., Li, J.-P. O., Cesareo, M., Giannini, C., & Nucci, C. (2020) · Eye · doi:10.1038/s41433-020-0926-9 · Cited by 111
The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern
Akkız, H. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.849217 · Cited by 113
Rapid Identification of Emerging Pathogens: Coronavirus
Sampath, R., Hofstadler, S. A., Blyn, L. B., Eshoo, M. W., Hall, T. A., Massire, C., Levene, H., Hannis, J. C., Harrell, P. M., Neuman, B. W., et al. (2005) · Emerging infectious diseases · doi:10.3201/eid1103.040629 · Cited by 100
Severe Acute Respiratory Syndrome Coronavirus 7a Accessory Protein Is a Viral Structural Protein
Huang, C., Ito, N., Tseng, C.-T. K., & Makino, S. (2006) · Journal of Virology · doi:10.1128/jvi.00414-06 · Cited by 100
A clinicopathological study of three cases of severe acute respiratory syndrome (SARS)
Lang, Z.-W., Zhang, L.-J., Zhang, S.-J., Meng, X., Li, J.-Q., Song, C.-Z., Sun, L., Zhou, Y.-S., & Dwyer, D. E. (2003) · Pathology · doi:10.1080/00313020310001619118 · Cited by 99
Coronaviruses and the human airway: a universal system for virus-host interaction studies
Jónsdóttir, H. R., & Dijkman, R. (2016) · Virology Journal · doi:10.1186/s12985-016-0479-5 · Cited by 106
Skariyachan, S., Challapilli, S. B., Packirisamy, S., Kumargowda, S. T., & Sridhar, V. S. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00569 · Cited by 109
SARS coronavirus induces apoptosis in Vero E6 Cells
Yan, H., Xiao, G., Zhang, J., Hu, Y., Yuan, F., Cole, D. K., Zheng, C., & Gao, G. F. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20094 · Cited by 99
Spurgers, K. B., Sharkey, C. M., Warfield, K. L., & Bavari, S. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2007.12.008 · Cited by 107
Clinical course and management of SARS in health care workers in Toronto: a case series.
Avendaño, M. A., Derkach, P., & Swan, S. (2003) · Europe PMC (PubMed Central) · Cited by 99
SARS: clinical virology and pathogenesis
NICHOLLS, J., DONG, X., JIANG, G., & PEIRIS, M. (2003) · Respirology · doi:10.1046/j.1440-1843.2003.00517.x · Cited by 98
Chen, Z., Wang, Y., Ratia, K., Mesecar, A. D., Wilkinson, K. D., & Baker, S. C. (2007) · Journal of Virology · doi:10.1128/jvi.02747-06 · Cited by 99
Activation of NF-κB by the Full-length Nucleocapsid Protein of the SARS Coronavirus
Liao, Q., Ye, L.-B., Timani, K. A., Zen, Y., She, Y., Li, Y., & Wu, Z.-H. (2005) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2005.00082.x · Cited by 98
Sarkar, B., Ullah, M. A., Johora, F. T., Taniya, M. A., & Araf, Y. (2020) · Immunobiology · doi:10.1016/j.imbio.2020.151955 · Cited by 101
SARS‐CoV ‐2 asymptomatic and symptomatic patients and risk for transfusion transmission
Corman, V. M., Rabenau, H. F., Adams, O., Oberle, D., Funk, M. B., Keller‐Stanislawski, B., Timm, J., Drosten, C., & Ciesek, S. (2020) · Transfusion · doi:10.1111/trf.15841 · Cited by 98
Self-citationDrug Discovery Strategies for SARS-CoV-2
Shyr, Z. A., Gorshkov, K., Chen, C. Z., & Zheng, W. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000123 · Cited by 102
Global acceptance and hesitancy of COVID-19 vaccination: A narrative review
Hassan, W., Kazmi, S. K., Tahir, M. J., Ullah, I., Royan, H. A., Fahriani, M., Nainu, F., & Viveiros-Rosa, S. G. (2021) · Narra J · doi:10.52225/narra.v1i3.57 · Cited by 108
Lu, B., Huang, Y. P., Huang, L., Bao, L., Zheng, Z., Chen, Z., Chen, J., Hu, Q., & Wang, H. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03231.x · Cited by 97
Sumoylation of the nucleocapsid protein of severe acute respiratory syndrome coronavirus
Li, Q., Xiao, H., Tam, J. P., & Liu, D. X. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.039 · Cited by 97
Struck, A., Axmann, M., Pfefferle, S., Drosten, C., & Meyer, B. (2012) · Antiviral Research · doi:10.1016/j.antiviral.2011.12.012 · Cited by 97
Self-citationHigh-Resolution CT Findings of Severe Acute Respiratory Syndrome at Presentation and After Admission
Müller, N. L., OOI, G. C., Khong, P. L., Zhou, L. J., TSANG, K. W. T., & Nicolaou, S. (2004) · American Journal of Roentgenology · doi:10.2214/ajr.182.1.1820039 · Cited by 97
Wahed, A. A. E., Patel, P., Heidenreich, D., Hufert, F. T., & Weidmann, M. (2013) · PLoS Currents · doi:10.1371/currents.outbreaks.62df1c7c75ffc96cd59034531e2e8364 · Cited by 97
The Involvement of Natural Killer Cells in the Pathogenesis of Severe Acute Respiratory Syndrome
(2004) · American Journal of Clinical Pathology · doi:10.1309/wpk7y2xknf4cbf3r · Cited by 91
Phylogenetic and phylodynamic analyses of SARS-CoV-2
Nie, Q., Li, X.-G., Chen, W., Liu, D., Chen, Y.-Y., Li, H.-T., Li, D.-Y., Tian, M., Tan, W., & Zai, J. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198098 · Cited by 100
A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening
Gorgulla, C., Padmanabha Das, K. M., Leigh, K. E., Cespugli, M., Fischer, P. D., Wang, Z.-F., Tesseyre, G., Pandita, S., Shnapir, A., Calderaio, A., et al. (2021) · iScience · doi:10.1016/j.isci.2020.102021 · Cited by 93
Application of Nanotechnology in the COVID-19 Pandemic
Yang, D. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s296383 · Cited by 107
Mishra, A. R., Rani, P., Krishankumar, R., Ravichandran, K. S., & Kar, S. (2021) · Applied Soft Computing · doi:10.1016/j.asoc.2021.107155 · Cited by 100
A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation
Kang, L., He, G., Sharp, A. K., Wang, X., Brown, A. M., Michalak, P., & Weger-Lucarelli, J. (2021) · Cell · doi:10.1016/j.cell.2021.07.007 · Cited by 105
Surrogate viruses for testing virucidal efficacy of chemical disinfectants
Steinmann, J. (2004) · Journal of Hospital Infection · doi:10.1016/j.jhin.2003.12.030 · Cited by 105
Molecular mechanisms of severe acute respiratory syndrome (SARS)
Groneberg, D. A., Hilgenfeld, R., & Zabel, P. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-8 · Cited by 107
Replicative Capacity of MERS Coronavirus in Livestock Cell Lines
Eckerle, I., Corman, V. M., Müller, M. A., Lenk, M., Ulrich, R. G., & Drosten, C. (2013) · Emerging infectious diseases · doi:10.3201/eid2002.131182 · Cited by 96
Self-citationAn animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus
Qin, C., Wang, J., Wei, Q., She, M., Marasco, W. A., Jiang, H., Tu, X., Zhu, H., Ren, L., Gao, H., et al. (2005) · The Journal of Pathology · doi:10.1002/path.1769 · Cited by 97
Vallamkondu, J., John, A. A., Wani, W. Y., Ramadevi, S., Jella, K. K., Reddy, P. H., & Kandimalla, R. J. L. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165889 · Cited by 117
The vision of point-of-care PCR tests for the COVID-19 pandemic and beyond
Zhu, H., Zhang, H., Ni, S., Korabečná, M., Yobaş, L., & Neužil, P. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.115984 · Cited by 102
Marengoni, A., Zucchelli, A., Vetrano, D. L., Armellini, A., Botteri, E., Nicosia, F., Romanelli, G., Beindorf, E. A., Giansiracusa, P., Garrafa, E., et al. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa291 · Cited by 108
Treatment and vaccines for severe acute respiratory syndrome
Groneberg, D. A., Poutanen, S. M., Low, D. E., Lode, H. M., Welte, T., & Zabel, P. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)01307-1 · Cited by 107
Renois, F., Talmud, D., Huguenin, A., Moutte, L., Strady, C., Cousson, J., Lévêque, N., & Andréoletti, L. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00733-10 · Cited by 108
Severe acute respiratory syndrome (SARS): a review
Vijayanand, P., Wilkins, E., & Woodhead, M. A. (2004) · Clinical Medicine · doi:10.7861/clinmedicine.4-2-152 · Cited by 101
Kumar, P., Kalaiarasan, G., Porter, A. E., Pinna, A., Kłosowski, M. M., Demokritou, P., Chung, K. F., Pain, C. C., Arvind, D. K., Arcucci, R., et al. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.143553 · Cited by 112
Virus discovery and recent insights into virus diversity in arthropods
Junglen, S., & Drosten, C. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.06.005 · Cited by 111
Self-citationPolyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide
Du, Q., Wang, S.-Q., Zhu, Y., Wei, D., Guo, H., Sirois, S., & Chou, K. (2004) · Peptides · doi:10.1016/j.peptides.2004.06.018 · Cited by 94
Yan, Q., Sun, X., Zheng, J., Mi, B., Zuo, H., Ruan, G., Hussain, A., Wang, Y., & Shi, Z. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108350 · Cited by 103
Lavillegrand, J., Garnier, M., Spaeth, A., Mario, N., Hariri, G., Pilon, A., Berti, E., Fieux, F., Thietart, S., Urbina, T., et al. (2021) · Annals of Intensive Care · doi:10.1186/s13613-020-00798-x · Cited by 105
Comparison of COVID-19 and influenza characteristics
Bai, Y., & Tao, X. (2021) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2000479 · Cited by 104
Avascular necrosis of bone in severe acute respiratory syndrome
Hong, N., & Du, X. K. (2004) · Clinical Radiology · doi:10.1016/j.crad.2003.12.008 · Cited by 96
Deming, D., Graham, R. L., Denison, M. R., & Baric, R. S. (2007) · Journal of Virology · doi:10.1128/jvi.00017-07 · Cited by 94
A complete sequence and comparative analysis of a SARS-associated virus (Isolate BJ01)
Qin, E.-D., Zhu, Q., Yu, M., Fan, B., Chang, G., Si, B., Baoan, Y., Peng, W., Jiang, T., Liu, B., et al. (2003) · Chinese Science Bulletin · doi:10.1007/bf03184203 · Cited by 94
Liu, C.-C., Chang, R.-E., & Chang, W.-C. (2004) · Infection Control & Hospital Epidemiology · doi:10.1086/502351 · Cited by 95
Evaluation of metal‐conjugated compounds as inhibitors of 3CL protease of SARS‐CoV
Hsu, J. T.-A., Kuo, C., Hsieh, H., Wang, Y.-C., Huang, K., Lin, C. P. C., Huang, P.-F., Chen, X., & Liang, P. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.08.015 · Cited by 94
A serological survey on neutralizing antibody titer of SARS convalescent sera
Zhang, J.-S., Chen, J.-T., Liu, Y.-X., Zhang, Z.-S., Gao, H., Liu, Y., Wang, X., Ning, Y., Liu, Y.-F., Gao, Q., et al. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20431 · Cited by 94
Severe acute respiratory syndrome (SARS): epidemiology and clinical features
Hui, D. S. C., Chan, M. C. H., Wu, A. K., & Ng, P. C. (2004) · Postgraduate Medical Journal · doi:10.1136/pgmj.2004.020263 · Cited by 92
The spectrum of pathological changes in severe acute respiratory syndrome (SARS)
Cheung, O.-Y., Chan, J. W. M., Ng, C. K., & Koo, C. (2004) · Histopathology · doi:10.1111/j.1365-2559.2004.01926.x · Cited by 93
Control Measures for SARS-CoV-2: A Review on Light-Based Inactivation of Single-Stranded RNA Viruses
Hadi, J. L., Dunowska, M., Wu, S., & Brightwell, G. (2020) · Pathogens · doi:10.3390/pathogens9090737 · Cited by 105
The impact of COVID-19 pandemic on malaria elimination
Zawawi, A., Alghanmi, M. S., Alsaady, I., Gattan, H. S., Zakai, H. A., & Couper, K. N. (2020) · Parasite Epidemiology and Control · doi:10.1016/j.parepi.2020.e00187 · Cited by 152
Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2
Xiao, X., Wang, C., Chang, D., Wang, Y., Dong, X., Jiao, T., Zhao, Z., Ren, L., Cruz, C. S. D., Sharma, L., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.586572 · Cited by 99
Olsen, S. J., Thamthitiwat, S., Chantra, S., Chittaganpitch, M., Fry, A. M., Simmerman, J. M., Baggett, H. C., Peret, T. C. T., Erdman, D. D., Benson, R. F., et al. (2010) · Epidemiology and Infection · doi:10.1017/s0950268810000646 · Cited by 102
Our Strategies for Fighting Severe Acute Respiratory Syndrome (SARS)
Zhong, N., & Zeng, G. Q. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200305-707oe · Cited by 92
Kumaki, Y., Wandersee, M. K., Smith, A., Zhou, Y., Simmons, G., Nelson, N. M., Bailey, K. W., Vest, Z. G., Li, J. K.-K., Chan, P. K. S., et al. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.02.003 · Cited by 101
A Melting Curve-Based Multiplex RT-qPCR Assay for Simultaneous Detection of Four Human Coronaviruses
Wan, Z., Zhang, Y., He, Z., Liu, J., Lan, K., Hu, Y., & Zhang, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111880 · Cited by 92
Dk, L., & Alkhovsky, S. V. (2020) · Problems of Virology · doi:10.36233/0507-4088-2020-65-2-62-70 · Cited by 107
Naik, B., Gupta, N., Ojha, R., Singh, S., Prajapati, V. K., & Prusty, D. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.05.184 · Cited by 96
COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice
Lutz, C. M., Maher, L. A., Lee, C., & Kang, W. (2020) · Human Genomics · doi:10.1186/s40246-020-00272-6 · Cited by 96
Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia
Akbari, A., & Rezaie, J. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01866-6 · Cited by 96
Anthropogenic Infection of Cats during the 2020 COVID-19 Pandemic
Hosie, M. J., Hofmann‐Lehmann, R., Hartmann, K., Egberink, H. F., Truyen, U., Addie, D., Belák, S., Boucraut‐Baralon, C., Frymus, T., Lloret, A., et al. (2021) · Viruses · doi:10.3390/v13020185 · Cited by 102
John, S. E. S., Tomar, S., Stauffer, S. R., & Mesecar, A. D. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.06.039 · Cited by 92
A molecular beacon, bead-based assay for the detection of nucleic acids by flow cytometry
Horejsh, D. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni015 · Cited by 92
Long-Term Persistence of IgG Antibodies in SARS-CoV Infected Healthcare Workers
Guo, X., Guo, Z., Duan, C., Chen, Z., Wang, G., Lu, Y., Li, M., & Lu, J. (2020) · medRxiv · doi:10.1101/2020.02.12.20021386 · Cited by 92
SARS: Epidemiology, Clinical Presentation, Management, and Infection Control Measures
Sampathkumar, P., Temesgen, Z., Smith, T. F. A., & Thompson, R. L. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.7.882 · Cited by 100
Persistent infection of SARS coronavirus in colonic cells in vitro
Chan, P. K. S., To, K., Lo, A. W. I., Cheung, J. L. K., Chu, I. M., Au, F. W. L., TONG, J. H. M., Tam, J. S., Sung, J. J. �., & Ng, H. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20138 · Cited by 99
Roh, C. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s31379 · Cited by 91
Structural insights into SARS coronavirus proteins
Bartlam, M. G., Yang, H., & Rao, Z. (2005) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2005.10.004 · Cited by 91
Severe acute respiratory syndrome: clinical and laboratory manifestations.
Lam, C. W. K., Chan, M. H. M., & Wong, C. K. (2004) · PubMed · Cited by 118
Karypidou, K., Ribone, S. R., Quevedo, M. A., Persoons, L., Pannecouque, C. C., Helsen, C., Claessens, F., & Dehaen, W. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.09.019 · Cited by 91
Lian, J., Jin, X., Hao, S., Jia, H., Cai, H. Q., Zhang, X., Hu, J., Zheng, L., Wang, X., Zhang, S., et al. (2020) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12758 · Cited by 94
Glycyrrhizin: An old weapon against a novel coronavirus
Chrzanowski, J., Chrzanowska, A., & Graboń, W. (2020) · Phytotherapy Research · doi:10.1002/ptr.6852 · Cited by 96
Inhibitors of SARS-CoV-2 PLpro
Calleja, D. J., Lessène, G., & Komander, D. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.876212 · Cited by 102
Phylogeny of the SARS Coronavirus
Eickmann, M., Becker, S., Klenk, H., Doerr, H. W., Stadler, K., Censini, S., Guidotti, S., Masignani, V., Scarselli, M., Mora, M., et al. (2003) · Science · doi:10.1126/science.302.5650.1504b · Cited by 91
Self-citationEsposito, S., Bosis, S., Niesters, H. G. M., Tremolati, E., Begliatti, E., Rognoni, A., Tagliabue, C., Principi, N., & Osterhaus, A. D. M. E. (2006) · Journal of Medical Virology · doi:10.1002/jmv.20745 · Cited by 91
Self-citationInflammatory Cytokine Profile in Children With Severe Acute Respiratory Syndrome
Ng, P. C., Lam, C. W. K., Li, A. M., Wong, C. K., Cheng, F. W. T., Leung, T. F., Hon, E. K. L., Chan, I. H. S., Li, C. K., Fung, K. S. C., et al. (2004) · Pediatrics · doi:10.1542/peds.113.1.e7 · Cited by 90
Photocatalytic Nanowires‐Based Air Filter: Towards Reusable Protective Masks
Horváth, E., Rossi, L., Mercier, C., Lehmann, C., Sienkiewicz, A., & Forró, L. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202004615 · Cited by 90
SARS-CoV-2 Envelope (E) protein interacts with PDZ-domain-2 of host tight junction protein ZO1
Shepley‐McTaggart, A., Sagum, C. A., Oliva, I. B., Rybakovsky, E., DiGuilio, K., Liang, J., Bedford, M. T., Cassel, J. A., Sudol, M., Mullin, J. M., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251955 · Cited by 90
Liu, Y., Wang, B., Liang, Q.-Z., Shi, F.-S., Ji, C.-M., Yang, X.-L., Yang, Y.-L., Qin, P., Chen, R., & Huang, Y.-W. (2021) · Journal of Virology · doi:10.1128/jvi.01118-21 · Cited by 90
He, W., Bollen, N., Xu, Y., Zhao, J., Dellicour, S., Yan, Z., Gong, W., Zhang, C., Zhang, L., Lu, M., et al. (2021) · Molecular Biology and Evolution · doi:10.1093/molbev/msab364 · Cited by 96
Proteomic analysis on structural proteins of Severe Acute Respiratory Syndrome coronavirus
Ying, W., Hao, Y., Zhang, Y., Peng, W., Qin, E.-D., Cai, Y., Wei, K., Wang, J., Chang, G., Sun, W., et al. (2004) · PROTEOMICS · doi:10.1002/pmic.200300676 · Cited by 90
The substrate specificity of SARS coronavirus 3C-like proteinase
Fan, K., Ma, L., Han, X., Liang, H., Wei, P., Liu, Y., & Lai, L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.061 · Cited by 90
Murine Coronavirus Replication Induces Cell Cycle Arrest in G0/G1Phase
Chen, C., & Makino, S. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5658-5669.2004 · Cited by 96
ZHOU, Z., POST, P., CHUBET, R., HOLTZ, K., MCPHERSON, C., PETRIC, M., & COX, M. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.01.059 · Cited by 90
Potential beneficial role of probiotics on the outcome of COVID-19 patients: An evolving perspective
Santacroce, L., Inchingolo, F., Topi, S., Prete, R. D., Cosola, M. D., Charitos, I. A., & Montagnani, M. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.12.040 · Cited by 104
A systematic review of human coronaviruses survival on environmental surfaces
Marzoli, F., Bortolami, A., Pezzuto, A., Mazzetto, E., Piro, R., Terregino, C., Bonfante, F., & Belluco, S. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.146191 · Cited by 99
Metadata
- Authors
- Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., Berger, A., Burguière, A.-M., Cinatl, J., Eickmann, M., Escriou, N., Grywna, K., Kramme, S., Manuguerra, J.-C., Müller, S., Rickerts, V., Stürmer, M., Vieth, S., Klenk, H.-D., Osterhaus, A. D. M. E., Schmitz, H., & Doerr, H. W.
- Affiliations
- Goethe University Frankfurt (DE)
- From the Bernhard Nocht Institute for Tropical Medicine, National Reference Center for Tropical Infectious Diseases, Hamburg (C.D., S.G., M.P., K.G., S.K., S.M., S.V., H.S.); the Institute of Medical Virology (W.P., H.R., A.B., J.C., M.S., H.W.D.) and the Medical Clinic III (H.-R.B., V.R.), Johann Wolfgang Goethe University, Frankfurt am Main; and the Institute of Virology, Philipps University, Marburg (S.B., L.K., M.E., H.-D.K.) — all in Germany; the Pasteur Institute, Molecular Genetics of Respiratory...
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-05-15
- Volume
- 348
- Issue
- 20
- Pages
- 1967-1976
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2132260239
- Semantic Scholar
- 79116f5bb552a1a23de85d03899ab0b3763c81ee
- Cited by
- 4,574
- References
- 10
- Citations by year
- 2026: 40 · 2025: 91 · 2024: 141 · 2023: 193 · 2022: 361 · 2021: 646 · 2020: 913 · 2019: 50 · 2018: 45 · 2017: 49 · 2016: 60 · 2015: 65 · 2014: 91 · 2013: 83 · 2012: 93
- FWCI
- 222.93
- Type
- journal article
- Language
- en
- Open access
- green
- pure.eur.nl
- Licence
- other-oa
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS, novel coronavirus, SARS-CoV, virus identification, viral RNA detection, seroconversion, fecal viral shedding, plasma viral RNA
- MeSH terms
- Adult, Amino Acid Sequence, Animals, Base Sequence, Cattle, Disease Outbreaks, DNA, Viral, Female, Humans, Male, Molecular Sequence Data, Phylogeny, RNA, Viral, Sequence Homology, Nucleic Acid, Sputum, Polymerase Chain Reaction, Coronavirus, Severe Acute Respiratory Syndrome, Severe acute respiratory syndrome-related coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.